Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Tax Provisions (2017 - 2025)

Fortress Biotech (FBIO) has 6 years of Tax Provisions data on record, last reported at $231000.0 in Q4 2024.

  • For Q4 2024, Tax Provisions fell 39.21% year-over-year to $231000.0; the TTM value through Dec 2024 reached $300000.0, down 42.42%, while the annual FY2024 figure was $300000.0, 42.42% down from the prior year.
  • Tax Provisions reached $231000.0 in Q4 2024 per FBIO's latest filing, up from $69000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $473000.0 in Q4 2021 and bottomed at $69000.0 in Q3 2024.
  • Average Tax Provisions over 4 years is $282333.3, with a median of $305500.0 recorded in 2023.
  • Peak YoY movement for Tax Provisions: decreased 5.0% in 2023, then crashed 51.06% in 2024.
  • A 4-year view of Tax Provisions shows it stood at $473000.0 in 2021, then decreased by 15.43% to $400000.0 in 2022, then dropped by 5.0% to $380000.0 in 2023, then tumbled by 39.21% to $231000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $231000.0 in Q4 2024, $69000.0 in Q3 2024, and $380000.0 in Q4 2023.